REZOLUTE

Lobbying client · California · filed 2025 to 2026

clinical stage biopharmaceutical company creating therapies for metabolic diseases

$170,000 Reported spend

6 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (56757), not by name.

Firms hired 1

THE KPM GROUP DC LLC $170,000 6 filings

Bills named in these filings 1

S 4426
Promising Pathway Act 2.0

4 filings

Reported by year 2 years

2026 $80,000 2 filings
2025 $90,000 4 filings

Issues lobbied 2

Pharmacy 5
Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 7 total

2A

THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 28, 2026

View → Q2Y

THE KPM GROUP DC LLC Amended

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 19, 2026

View → Q1

THE KPM GROUP DC LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $40,000 income · posted Apr 20, 2026

View → Q4

THE KPM GROUP DC LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 14, 2026

View → Q3

THE KPM GROUP DC LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 17, 2025

View → Q2

THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $30,000 income · posted Jul 17, 2025

View → RA

THE KPM GROUP DC LLC

2nd Quarter (Apr 1 - June 30) 2025 · posted Jul 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.